company background image
A000230 logo

Ildong Holdings KOSE:A000230 Stock Report

Last Price

₩7.36k

Market Cap

₩83.1b

7D

8.6%

1Y

-27.1%

Updated

24 Dec, 2024

Data

Company Financials

Ildong Holdings Co., Ltd.

KOSE:A000230 Stock Report

Market Cap: ₩83.1b

A000230 Stock Overview

Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. More details

A000230 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Ildong Holdings Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ildong Holdings
Historical stock prices
Current Share Price₩7,360.00
52 Week High₩12,220.00
52 Week Low₩5,470.00
Beta0.76
1 Month Change3.66%
3 Month Change-11.33%
1 Year Change-27.06%
3 Year Change-47.62%
5 Year Change-30.38%
Change since IPO289.29%

Recent News & Updates

Revenues Working Against Ildong Holdings Co., Ltd.'s (KRX:000230) Share Price

Dec 18
Revenues Working Against Ildong Holdings Co., Ltd.'s (KRX:000230) Share Price

Is Ildong Holdings (KRX:000230) Using Debt Sensibly?

Nov 12
Is Ildong Holdings (KRX:000230) Using Debt Sensibly?

Recent updates

Revenues Working Against Ildong Holdings Co., Ltd.'s (KRX:000230) Share Price

Dec 18
Revenues Working Against Ildong Holdings Co., Ltd.'s (KRX:000230) Share Price

Is Ildong Holdings (KRX:000230) Using Debt Sensibly?

Nov 12
Is Ildong Holdings (KRX:000230) Using Debt Sensibly?

Ildong Holdings Co., Ltd. (KRX:000230) Shares Fly 39% But Investors Aren't Buying For Growth

Aug 20
Ildong Holdings Co., Ltd. (KRX:000230) Shares Fly 39% But Investors Aren't Buying For Growth

Is Ildong Holdings Co., Ltd. (KRX:000230) A Good Dividend Stock?

Apr 28
Is Ildong Holdings Co., Ltd. (KRX:000230) A Good Dividend Stock?

Can You Imagine How Ildong Holdings' (KRX:000230) Shareholders Feel About The 60% Share Price Increase?

Mar 04
Can You Imagine How Ildong Holdings' (KRX:000230) Shareholders Feel About The 60% Share Price Increase?

Ildong Holdings (KRX:000230) Has Debt But No Earnings; Should You Worry?

Feb 06
Ildong Holdings (KRX:000230) Has Debt But No Earnings; Should You Worry?

Tread With Caution Around Ildong Holdings Co., Ltd.'s (KRX:000230) 0.7% Dividend Yield

Jan 11
Tread With Caution Around Ildong Holdings Co., Ltd.'s (KRX:000230) 0.7% Dividend Yield

How Much Of Ildong Holdings Co., Ltd. (KRX:000230) Do Insiders Own?

Dec 16
How Much Of Ildong Holdings Co., Ltd. (KRX:000230) Do Insiders Own?

How Much Have Ildong Holdings (KRX:000230) Shareholders Earned On Their Investment Over The Last Five Years?

Nov 20
How Much Have Ildong Holdings (KRX:000230) Shareholders Earned On Their Investment Over The Last Five Years?

Shareholder Returns

A000230KR PharmaceuticalsKR Market
7D8.6%1.0%-0.9%
1Y-27.1%2.4%-9.0%

Return vs Industry: A000230 underperformed the KR Pharmaceuticals industry which returned 4.3% over the past year.

Return vs Market: A000230 underperformed the KR Market which returned -9% over the past year.

Price Volatility

Is A000230's price volatile compared to industry and market?
A000230 volatility
A000230 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A000230 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A000230's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194180Dae-Chang Parkwww.ildongholdings.co.kr

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics.

Ildong Holdings Co., Ltd. Fundamentals Summary

How do Ildong Holdings's earnings and revenue compare to its market cap?
A000230 fundamental statistics
Market cap₩83.11b
Earnings (TTM)-₩23.92b
Revenue (TTM)₩649.81b

0.1x

P/S Ratio

-3.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A000230 income statement (TTM)
Revenue₩649.81b
Cost of Revenue₩424.61b
Gross Profit₩225.20b
Other Expenses₩249.12b
Earnings-₩23.92b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.12k
Gross Margin34.66%
Net Profit Margin-3.68%
Debt/Equity Ratio162.8%

How did A000230 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

-5%

Payout Ratio

Does A000230 pay a reliable dividends?

See A000230 dividend history and benchmarks
When do you need to buy A000230 by to receive an upcoming dividend?
Ildong Holdings dividend dates
Ex Dividend DateDec 27 2024
Dividend Pay DateApr 21 2025
Days until Ex dividend2 days
Days until Dividend pay date117 days

Does A000230 pay a reliable dividends?

See A000230 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 10:18
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ildong Holdings Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kidal BaeShinhan Investment Corp.